BSE filing, BSE: 543765. Summary written from the filing by ALFA Finder's alert engine.
Earthstahl & Alloys Ltd: key numbers
- Share price
- ₹14.00
- Market cap
- ₹17.14 Cr
- Revenue (annual)
- ₹61.59 Cr
- Net profit (annual)
- ₹-4.90 Cr
- P/E (TTM)
- -3.5×Sector 16.9×
- Promoter holding
- 73.53%
- FII holding
- 0.88%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Earthstahl & Alloys Ltd
All →Earthstahl & Alloys Annual General Meeting
Earthstahl & Alloys Limited held its 17th Annual General Meeting on 29th September 2026, transacting standard agenda items including adoption of financial statements and director re-appointments.
Earthstahl & Alloys Legal & Regulatory
Earthstahl & Alloys Ltd has paid a fine of Rs. 1,180 to BSE, complying with Regulation 6(1) regarding the appointment of a company secretary.
- Value
- ₹0.00 Cr
Earthstahl & Alloys Annual General Meeting
Earthstahl & Alloys Limited has scheduled its 17th Annual General Meeting for September 29, 2026, via video conferencing. Remote e-voting details are also provided.
Earthstahl & Alloys Legal & Regulatory
Earthstahl & Alloys reported an exchange-imposed fine of Rs. 1,000 for delayed compliance regarding the appointment of a company secretary.
Earthstahl & Alloys Management Change
The Board approved the reappointment of Mr. Prawin Somani and Mr. Rajesh Somani as Whole Time Directors of the company for five years.
Earthstahl & Alloys Other Announcement
Earthstahl & Alloys Limited appointed M/s Himanshu R & Co. and M/s S.G. Kankani & Associates as auditors for FY 2026-27. These are routine professional service appointments.
- Execution
- FY 2026-27
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.